RXRX — Recursion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Recursion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	517	550	392	594	743
Net Total Accounts Receivable
Net Total Receivables	9.09	2.75	3.09	49.2	24.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	535	570	438	714	813
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	64.7	121	120	233	169
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	610	701	654	1,449	1,474
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.7	100	93.2	187	148
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	67.4	215	190	414	343
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	543	486	463	1,035	1,131
Total Liabilities & Shareholders' Equity	610	701	654	1,449	1,474
Total Common Shares Outstanding